Cancer

Woman using her phone under blanket in bed at night. (Getty Images)

Evidence Supports Link Between Breast Cancer, Light Exposure at Night

Artificial light has transformed the night sky, a change researchers continue to link to health problems.

UConn Health's study will be Journal of Neuroscience Research cover story.

A Better View of How Tumors Form in the Eye

UConn Health neuroscientists believe they are closing in on an explanation for the reason our corneas, the transparent layer that forms the front of our eyes, have a natural ability to prevent the formation of tumors.

Female dermatologist examining female patient's skin with dermascope, carefully looking for signs of skin cancer. (Getty Images)

Melanoma’s Signature

On Melanoma Monday, UConn Health dermatologist Sam Dadras discusses his research, which found a molecular signal that could distinguish which skin cancers need more aggressive treatment.

More PSMA, more problems. Prostate cells with more prostate-specific membrane antigen (PSMA) have more cancer cells (purple), growing in a more disorganized way, than the open ducts in a prostate whose cells have little PSMA. (Caromile and Shapiro/UConn Health Image)

Mark of Malignancy Identified in Prostate Cancer

Researchers at UConn Health have identified a protein that appears to indicate how aggressive a prostate cancer will be, potentially leading the way to new treatments.

This study built upon earlier research by Dr. Andrew Arnold of UConn, and published in the New England Journal of Medicine.

Scientists Pave Path for Tackling Rare Cancers Without Effective Treatments

Genomic analysis is opening the doors to diseases that could never have been understood through traditional biomedical research because there simply aren’t enough patients to observe.

Illustration of an X-ray view of a human colon with tumor. (Getty Images)

Colonoscopy Just the Start in Preventing Colorectal Cancer

Research at UConn Health has uncovered predictors of the development of polyps that can lead to colorectal cancer.

Dr. Ching Lau speaks at a press event to announce the 'Smash Childhood Cancer' global crowdsourcing research initiative. From left, Juan Hindo of IBM, Gov. Dannel P. Malloy, and Dr. Jim Shmerling, CEO of the Connecticut Children's Medical Center. (Lauren Woods/UConn Health Photo)

UConn Health Physician is US Lead on ‘Smash Childhood Cancer’

Pediatric cancer researcher Dr. Ching Lau is spearheading IBM's global crowdsourcing research effort to find new treatments for childhood cancer in the U.S.

Kepeng Wang, assistant professor of immunology, right, with Kasandra Rodriguez, a research associate at CaroGen Corp.'s technology incubation lab in Farmington on Dec. 12, 2016. (Peter Morenus/UConn Photo)

UConn Health Researchers Work with Startup on Colon Cancer Vaccine

CaroGen’s proprietary technology platform will be applied to a specific target studied by two immunologists at UConn Health.

Pramod Srivastava (left), director of the Carole and Ray Neag Comprehensive Cancer Center at UConn Health, oversees students Nandini Acharya (foreground) and Stephanie Floyd in his lab. (Carolyn Pennington/UConn Health Photo)

Divining Tumor Markers from DNA

UConn Health researchers are part of a cutting-edge initiative to discover cancer markers known as neoantigens, that will further the search for cancer immunotherapies.

Dr. Omar Ibrahim, right, director of thoracic oncology at the Carole and Ray Neag Comprehensive Cancer Center, UConn Health, and Dr. Electra Kaloudis, section head of thoracic imaging in the Department of Diagnostic Imaging and Therapeutics, look over a low dose CT scan. (Janine Gelineau/UConn Health Photo)

Early Detection of Lung Cancer Saves Lives

'Early detection is a patient’s best chance for a lung cancer cure,' says UConn Health's Dr. Omar Ibrahim.